New pharmacological options in the treatment of Alzheimer's disease

被引：2
|
作者：
Kleinova, L. [1 ,2 ]
Cerman, J. [2 ]
Hlavka, J. [3 ]
Hort, J. [2 ]
机构：
[1] 1 LF UK, Vseobecne Lekarstvi, Prague, Czech Republic
[2] Neurol Klin 2 LF UK, Kognitivni Ctr, V Uvalu 84, Prague 15006, Czech Republic
[3] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2022年 / 85卷 / 06期
关键词：
Alzheimer?s disease; phase three testing  of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection; BETA; TRAMIPROSATE; INHIBITION; GUANFACINE; DEMENTIA; TRIAL;
D O I：
10.48095/cccsnn2022462
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
引用
收藏
页码：462 / 469
页数：8
相关论文
共 50 条
  • [21] An update on drug treatment options of Alzheimer's disease
    Allgaier, Michael
    Allgaier, Clemens
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 : 1344 - 1354
  • [22] Current approaches to the pharmacological treatment of Alzheimer's disease
    Tan, Edwin C. K.
    Hilmer, Sarah N.
    Garcia-Ptacek, Sara
    Bell, J. Simon
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2018, 47 (09) : 586 - 592
  • [23] Pharmacological treatment of cognitive disorders in Alzheimer's disease
    Senin, U
    Cherubini, A
    Palumbo, B
    Mecocci, P
    FUNCTIONAL NEUROLOGY, 1997, 12 (3-4) : 211 - 212
  • [24] Insulin: An Emerging Treatment for Alzheimer's Disease Dementia?
    Morris, Jill K.
    Burns, Jeffrey M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (05) : 520 - 527
  • [25] Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies
    Broadstock, Martin
    Ballard, Clive
    Corbett, Anne
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1797 - 1810
  • [26] Facing the new diagnostic and treatment options of Alzheimer's disease: The necessity of informed consent
    Karneboge, Jonas
    Haberstroh, Julia
    Geschke, Katharina
    Perry, Julia
    Radenbach, Katrin
    Jessen, Frank
    Rostamzadeh, Ayda
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [27] A new therapeutic target in Alzheimer's disease treatment: Attention to butyrylcholinesterase
    Greig, NH
    Utsuki, T
    Yu, QS
    Zhu, XX
    Holloway, HW
    Perry, T
    Lee, B
    Ingram, DK
    Lahiri, DK
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (03) : 159 - 165
  • [28] New Pharmacological Options for Treating Advanced Parkinson's Disease
    Devos, David
    Moreau, Caroline
    Dujardin, Kathy
    Cabantchik, Ioav
    Defebvre, Luc
    Bordet, Regis
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1640 - 1652
  • [29] Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment
    dos Santos Picanco, Leide Caroline
    Ozela, Priscilla F.
    de Brito Brito, Maiara de Fatima
    Pinheiro, Abrado A.
    Padilha, Elias C.
    Braga, Francinaldo S.
    Tomich de Paula da Silva, Carlos Henrique
    Rodrigues dos Santos, Cleydson Breno
    Rosa, Joaquin M. C.
    da Silva Hage-Melim, Lorane Izabel
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (26) : 3141 - 3159
  • [30] A Nanoinformatics Approach to Evaluate the Pharmacological Properties of Nanoparticles for the Treatment of Alzheimer's Disease
    Nawaz, Muhammad Zohaib
    Attique, Syed Awais
    Qurat-Ul-Ain
    Alshammari, Fahdah Ayed
    Alhamdi, Heba Waheeb
    Alghamdi, Huda Ahmed
    Yan, Wei
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (04) : 730 - 737
12345